Clinical Trial Update: Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery [NA]

View source ↗

Summary

Clinical trial assessing the use of Fludeoxyglucose F-18 PET imaging to detect lymph node metastasis in patients with stage I or stage II non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lung Cancer | NA | Status: COMPLETED